Loading organizations...
AI-driven drug discovery and antibody engineering platform.
Helixon has raised $74.7M across 1 funding round.
Helixon has raised $74.7M in total across 1 funding round.
Helixon has raised $74.7M in total across 1 funding round.
Helixon's investors include 5Y Capital, Gaorong Capital, Hillhouse Capital, Neumann Capital, Xianghe Capital.
Helixon has raised $74.7M across 1 funding round. Most recently, it raised $74.7M Series A in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 22, 2022 | $74.7M Series A | 5Y Capital | Gaorong Capital, Hillhouse Capital, Neumann Capital, Xianghe Capital |